The honest way to evaluate a pre-revenue battery company is to size the bet, not the slideware. Per QuantumScape's filings, with the XBRL series assembled through EdgarBeast, annual research and development expense ran approximately $348 million in 2023, about $383 million in 2024, and roughly $376 million in 2025. That is over $1.1 billion of development spend across three years.
What is striking is the steadiness. R&D did not spike and fade; it held in a tight band near $350–$385 million a year, as the FY2025 10-K figures show. A company spending at a consistent high level is one running a sustained, capital-intensive engineering program — the opposite of a project that can be cheaply paused if a quarter disappoints.
Does it pencil? Only conditionally. There is no revenue line yet to absorb this cost, so the spend is justified entirely by an option: that solid-state cells reach automotive-grade commercialization and a licensing or production model eventually earns a return on the cumulative investment. The Q1 2026 10-Q shows the burn continuing into 2026, near $84.6 million for the quarter.
The unit economics that matter here are not LCOS or margin — they are cost-per-year-of-runway versus milestones-cleared-per-year. Every year of ~$375 million spend has to buy a discrete, demonstrable step toward a shippable cell, because the financing market funds milestones, not promises. Flat spend with clear progress is a strategy; flat spend with vague progress is a clock.
We don't advise; we count. The cumulative R&D figure is the cleanest measure of the conviction priced into a solid-state developer, and at over $1.1 billion in three years the bar for the eventual payoff is correspondingly high. Figures from the filings on sec.gov, indexed by EdgarBeast.